Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

HOOKIPA Pharma Inc. (HOOK)

11.99   0.02 (0.17%) 02-21 16:00
Open: 12 Pre. Close: 11.97
High: 12.16 Low: 11.77
Volume: 38,758 Market Cap: 305M
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.166 - 12.226 12.226 - 12.287
Low: 11.63 - 11.692 11.692 - 11.754
Close: 11.89 - 11.989 11.989 - 12.088

Technical analysis

as of: 2020-02-21 4:30:50 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.31     One year: 16.78
Support: Support1: 11.07    Support2: 9.21
Resistance: Resistance1: 13.11    Resistance2: 14.37
Pivot: 12.43
Moving Average: MA(5): 12.06     MA(20): 12.47
MA(100): 9.77     MA(250):
MACD: MACD(12,26): 0.11     Signal(9): 0.27
Stochastic oscillator: %K(14,3): 5.17     %D(3): 6.03
RSI: RSI(14): 48.88
52-week: High: 14.38  Low: 6.06  Change(%): -14.4
Average Vol(K): 3-Month: 11914  10-Days: 5724

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HOOK has closed above bottom band by 27.8%. Bollinger Bands are 26.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 23 Jan 2020 14:00:00 +0000
2 Small-Cap Biotech Stocks to Watch in 2020

Fri, 12 Jul 2019 18:03:35 +0000
Health Care Sector Update for 07/12/2019: HOOK,MDGS,ILMN

Fri, 12 Jul 2019 19:59:23 +0000
Health Care Sector Update for 07/12/2019: OHRP,HOOK,ILMN,NBSE

Fri, 12 Jul 2019 13:14:54 +0000
Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN

Tue, 04 Jun 2019 21:13:01 +0000
5 Top Gainers In Pharma Sector (CVM, ALNA, SOLY...)

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 21.59
Shares Float (M) 6.85
% Held by Insiders 14.94
% Held by Institutions 49.21
Shares Short (K) 298
Shares Short P. Month (K)

Stock Financials

EPS -2.960
Book Value (p.s.) 4.950
PEG Ratio 1.07
Profit Margin -258.77
Operating Margin -298.90
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 7.3
Gross Profit (p.s.) -0.664
Sales Per Share
EBITDA (p.s.) -1.747
Qtrly Earnings Growth
Operating Cash Flow (M) -39.31
Levered Free Cash Flow (M)

Stock Valuations

P/E -4.05
P/E Growth Ratio
P/BV 2.42
P/S 10.51
P/CF -6.59

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.